IS7015A - PDE 4 inhibitor and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease - Google Patents

PDE 4 inhibitor and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease

Info

Publication number
IS7015A
IS7015A IS7015A IS7015A IS7015A IS 7015 A IS7015 A IS 7015A IS 7015 A IS7015 A IS 7015A IS 7015 A IS7015 A IS 7015A IS 7015 A IS7015 A IS 7015A
Authority
IS
Iceland
Prior art keywords
pde
cocaine
obstructive
inhibitor
disease
Prior art date
Application number
IS7015A
Other languages
Icelandic (is)
Inventor
A. Armstrong Roisin
W. Watson John
Yeadon Michael
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0129275A external-priority patent/GB0129275D0/en
Priority claimed from GB0129396A external-priority patent/GB0129396D0/en
Priority claimed from GB0210238A external-priority patent/GB0210238D0/en
Priority claimed from GB0210240A external-priority patent/GB0210240D0/en
Priority claimed from PCT/EP2002/005726 external-priority patent/WO2002096463A1/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS7015A publication Critical patent/IS7015A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
IS7015A 2001-05-25 2003-10-31 PDE 4 inhibitor and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease IS7015A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29360601P 2001-05-25 2001-05-25
US29384201P 2001-05-25 2001-05-25
GB0129275A GB0129275D0 (en) 2001-12-06 2001-12-06 Pharmaceutical combination
GB0129396A GB0129396D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
GB0210238A GB0210238D0 (en) 2002-05-03 2002-05-03 Pharmaceutical composition
GB0210240A GB0210240D0 (en) 2002-05-03 2002-05-03 Pharmaceutical combination
PCT/EP2002/005726 WO2002096463A1 (en) 2001-05-25 2002-05-24 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases

Publications (1)

Publication Number Publication Date
IS7015A true IS7015A (en) 2003-10-31

Family

ID=37667302

Family Applications (2)

Application Number Title Priority Date Filing Date
IS7015A IS7015A (en) 2001-05-25 2003-10-31 PDE 4 inhibitor and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease
IS7012A IS7012A (en) 2001-05-25 2003-10-31 Adenosine A2A receptor agonist and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS7012A IS7012A (en) 2001-05-25 2003-10-31 Adenosine A2A receptor agonist and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease

Country Status (1)

Country Link
IS (2) IS7015A (en)

Also Published As

Publication number Publication date
IS7012A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
EP1383743A4 (en) Dual inhibitors of pde 7 and pde 4
IL158776A0 (en) A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
GB2396179B (en) Drillable inflatable packer and methods of use
AU2003299509A8 (en) Crosslinked compounds and methods of making and using thereof
IL163743A0 (en) Haloacetamide and azide substituted compounds and methods of use thereof
NO20024528L (en) Protease inhibitor, pharmaceutical composition and use of the compound
NO20042147L (en) Heterocyclic compounds and processes for their use
IL160017A0 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
NO20024623L (en) A novel process for the preparation of condensed imidazopyridine derivative and new crystal form
IS6724A (en) Process for the preparation of N-aryl-anthranilic acids and their derivatives
GB0013378D0 (en) Use of therapeutic benzamide derivatives
NO20030034D0 (en) A combination of FBPase inhibitors and antidiabetic agents useful in the treatment of diabetes
NO20015542L (en) Process for the preparation and use of N-desmethylzopiclones
NO20033854D0 (en) N-but-3-enyl-norbuprenorphine and methods of use
IS7863A (en) 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use in the treatment of gastrointestinal disorders or disorders
HUP0304075A3 (en) Herbicidal mixture comprising a benzoyl derivative a fertilizer containing nitrogen and an adjuvant and use thereof
IS7864A (en) 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use in the treatment of gastrointestinal disorders or disorders
NO20052859D0 (en) Process for the preparation of resperidone and its intermediates
IS7015A (en) PDE 4 inhibitor and anti-cholinergic agent in a mixture for the treatment of obstructive cocaine disease
IS7025A (en) 4- (Phenyl-piperidin-4-ylidene-methyl) -benzamide derivatives and their use in the treatment of pain, anxiety or gastrointestinal disorders
NO20042810L (en) Venflaxine hydrochloride monohydrate and processes for its preparation
IL163926A0 (en) Crystal structure of phosphodiesterase 5 and use thereof
DK1228026T3 (en) 15-Hydroxyicosatetraenoic acid related compounds and methods of use
NO20034124L (en) Composition of a taxane and a cyclin-dependent kinase inhibitor
IS7024A (en) 4- (Phenyl-piperidin-4-ylidene-methyl) -benzamide derivatives and their use in the treatment of pain, anxiety or gastrointestinal disorders